Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 89 (RN7SKP89) is annotated as a pseudogene related to the 7SK small nuclear RNA gene. RN7SK itself is a well-studied, highly conserved, non-coding small nuclear RNA (snRNA) that is a critical regulator of RNA polymerase II transcription; it acts as a scaffold for ribonucleoprotein complexes involved in transcriptional repression and regulation of elongation, with significant roles in neuron differentiation, cell cycle regulation, and RNA processing[1][2][3]. However, pseudogenes such as RN7SKP89 share sequence similarity with functional genes but are generally nonfunctional and do not encode an active product or participate in canonical gene regulation. There is no evidence that RN7SK pseudogene 89 functions as a protein coding gene, regulatory RNA, or therapeutic target. There is also no known disease association, functional interaction, or drug targeting described for this specific pseudogene. Key context: - The true therapeutic, functional, and biological importance belongs to the functional gene RN7SK (7SK small nuclear RNA), not its pseudogenes[1][2][3]. - RN7SKP89 is "incorrect" as a molecular target for therapeutic discovery because, by standard genomic and pharmacologic definitions, pseudogenes typically lack transcriptional or biochemical activity and are not targeted for drug development. If a role for this specific pseudogene is defined in future research (e.g., regulatory non-coding RNA), this assessment should be revised. Summary: RN7SKP89 is a nonfunctional pseudogene, not a legitimate molecular or therapeutic target. Any structured information about molecular classification, function, disease role, or drug interaction should reference the actual 7SK small nuclear RNA or functional gene, not pseudogenes such as RN7SKP89.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 89 (RN7SKP89).